Skip to main content
. 2022 Jan 7;10(1):87. doi: 10.3390/vaccines10010087
PG pyoderma gangrenosum
COVID-19 coronavirus disease 2019
mRNA messenger ribonucleic acid
URTI upper respiratory tract infection
MRI magnetic resonance imaging
NPS nasopharyngeal swab
RT-PCR reverse transcription polymerase chain reaction
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
H&E hematoxylin and eosin
RAND research and development
UCLA University of California at Los Angeles